112 related articles for article (PubMed ID: 32391926)
1. Sorafenib induces pigmentation via the regulation of β-catenin signalling pathway in melanoma cells.
Kim KI; Jung KE; Shin YB; Kim CD; Yoon TJ
Exp Dermatol; 2022 Jan; 31(1):57-63. PubMed ID: 32391926
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin signaling inhibitor ICG-001 enhances pigmentation of cultured melanoma cells.
Kim KI; Jeong DS; Jung EC; Lee JH; Kim CD; Yoon TJ
J Dermatol Sci; 2016 Nov; 84(2):160-168. PubMed ID: 27567978
[TBL] [Abstract][Full Text] [Related]
3. Induction of pigmentation by a small molecule tyrosine kinase inhibitor nilotinib.
Kim KI; Jo JW; Lee JH; Kim CD; Yoon TJ
Biochem Biophys Res Commun; 2018 Sep; 503(4):2271-2276. PubMed ID: 29959921
[TBL] [Abstract][Full Text] [Related]
4. Citric acid promoted melanin synthesis in B16F10 mouse melanoma cells, but inhibited it in human epidermal melanocytes and HMV-II melanoma cells via the GSK3β/β-catenin signaling pathway.
Zhou S; Sakamoto K
PLoS One; 2020; 15(12):e0243565. PubMed ID: 33332393
[TBL] [Abstract][Full Text] [Related]
5. Citrus flavanone naringenin enhances melanogenesis through the activation of Wnt/β-catenin signalling in mouse melanoma cells.
Huang YC; Yang CH; Chiou YL
Phytomedicine; 2011 Nov; 18(14):1244-9. PubMed ID: 21802267
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells.
Su TR; Lin JJ; Tsai CC; Huang TK; Yang ZY; Wu MO; Zheng YQ; Su CC; Wu YJ
Int J Mol Sci; 2013 Oct; 14(10):20443-58. PubMed ID: 24129178
[TBL] [Abstract][Full Text] [Related]
7. GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes.
Bellei B; Flori E; Izzo E; Maresca V; Picardo M
Cell Signal; 2008 Oct; 20(10):1750-61. PubMed ID: 18602000
[TBL] [Abstract][Full Text] [Related]
8. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
[TBL] [Abstract][Full Text] [Related]
9. Novel Furocoumarin Derivatives Stimulate Melanogenesis in B16 Melanoma Cells by Up-Regulation of MITF and TYR Family via Akt/GSK3β/β-Catenin Signaling Pathways.
Niu C; Yin L; Aisa HA
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29509689
[TBL] [Abstract][Full Text] [Related]
10. Anti-melanogenic effects of Aster spathulifolius extract in UVB-exposed C57BL/6J mice and B16F10 melanoma cells through the regulation of MAPK/ERK and AKT/GSK3β signalling.
Hwang GY; Choung SY
J Pharm Pharmacol; 2016 Apr; 68(4):503-13. PubMed ID: 26993057
[TBL] [Abstract][Full Text] [Related]
11. Andrographolide suppresses melanin synthesis through Akt/GSK3β/β-catenin signal pathway.
Zhu PY; Yin WH; Wang MR; Dang YY; Ye XY
J Dermatol Sci; 2015 Jul; 79(1):74-83. PubMed ID: 25869056
[TBL] [Abstract][Full Text] [Related]
12. GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation.
Molagoda IMN; Karunarathne WAHM; Park SR; Choi YH; Park EK; Jin CY; Yu H; Jo WS; Lee KT; Kim GY
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906440
[TBL] [Abstract][Full Text] [Related]
13. The regulatory mechanism of melanogenesis by FTY720, a sphingolipid analogue.
Lee JE; Kim SY; Jeong YM; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Exp Dermatol; 2011 Mar; 20(3):237-41. PubMed ID: 21166720
[TBL] [Abstract][Full Text] [Related]
14. The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
Zheng L; Pan J
Curr Cancer Drug Targets; 2018; 18(10):988-998. PubMed ID: 29692251
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of 5-iodotubercidin on pigmentation.
Kim KI; Jeong HB; Ro H; Lee JH; Kim CD; Yoon TJ
Biochem Biophys Res Commun; 2017 Sep; 490(4):1282-1286. PubMed ID: 28684314
[TBL] [Abstract][Full Text] [Related]
16. The ion channel activator CyPPA inhibits melanogenesis via the GSK3β/β-catenin pathway.
Noh TK; Bang SH; Lee YJ; Cho HI; Jung MY; Kim I; Leem CH; Chang SE
Chem Biol Interact; 2019 Feb; 300():1-7. PubMed ID: 30597128
[TBL] [Abstract][Full Text] [Related]
17. The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells.
Niessner H; Beck D; Sinnberg T; Lasithiotakis K; Maczey E; Gogel J; Venturelli S; Berger A; Mauthe M; Toulany M; Flaherty K; Schaller M; Schadendorf D; Proikas-Cezanne T; Schittek B; Garbe C; Kulms D; Meier F
J Invest Dermatol; 2011 Feb; 131(2):468-79. PubMed ID: 20944654
[TBL] [Abstract][Full Text] [Related]
18. In melanoma, beta-catenin is a suppressor of invasion.
Arozarena I; Bischof H; Gilby D; Belloni B; Dummer R; Wellbrock C
Oncogene; 2011 Nov; 30(45):4531-43. PubMed ID: 21577209
[TBL] [Abstract][Full Text] [Related]
19. Cycloartane triterpenoid (23R, 24E)-23-acetoxymangiferonic acid inhibited proliferation and migration in B16-F10 melanoma via MITF downregulation caused by inhibition of both β-catenin and c-Raf-MEK1-ERK signaling axis.
Kaneda T; Matsumoto M; Sotozono Y; Fukami S; Nugroho AE; Hirasawa Y; Hamid A HA; Morita H
J Nat Med; 2019 Jan; 73(1):47-58. PubMed ID: 30084054
[TBL] [Abstract][Full Text] [Related]
20. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
